Original Article
Copyright ©2010 Baishideng.
World J Gastroenterol. Mar 28, 2010; 16(12): 1458-1464
Published online Mar 28, 2010. doi: 10.3748/wjg.v16.i12.1458
Table 3 Effect of HYRD on serum levels of PCIII, HA, LN and CIV (mean ± SD)
GroupsPCIII (μg/mL)HA (ng/mL)LN (ng/mL)CIV (ng/mL)
Control15.16 ± 15.12b205.30 ± 48.92a82.02 ± 8.8621.71 ± 1.76
Model35.73 ± 17.90563.82 ± 335.5489.57 ± 7.5929.20 ± 6.17
Low-dosage HYRD group27.87 ± 10.13464.19 ± 283.4179.86 ± 9.5226.38 ± 8.61
Medium-dosage HYRD group24.72 ± 10.87a256.46 ± 95.98b86.34 ± 8.3024.41 ± 4.46
High-dosage HYRD group20.34 ± 13.92b161.51 ± 48.29b83.26 ± 13.2026.22 ± 7.97